IMUGENE LIMITED - Charts / Financials

10.3%

30.5¢

Market Cap $90.22M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Day
Open	34.0¢		Day High	35.0¢		Day Low	30.5¢
Daily Volume	9967007

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
26	30.0¢	648154		2	30.5¢	1371967

Directors & Senior Management

Mr. Paul E. Hopper	Executive Chairman of the Board
Ms. Leslie Chong	Chief Executive Officer, Managing Director, Executive Director
Mr. Darren Keamy	Chief Financial Officer, Company Secretary
Dr. Bradley Glover	Chief Operating Officer
Dr. John Byon	Chief Medical Officer
Ms. Kimberlee Cobleigh Drapkin	Non-Executive Independent Director
Dr. Jakob Dupont	Non-Executive Independent Director
Dr. Lesley Russell	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.5¢		Change -0.035(10.3%)		Mkt cap ! $90.22M

Open	High	Low	Value	Volume
34.0¢	35.0¢	30.5¢	$3.123M	9.967M

Buyers (Bids)

No.	Vol.	Price($)
26	648154	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	1371967	2

View Market Depth

No.	Vol.	Price($)
25	635713	0.300
4	47442	0.295
4	47937	0.290
1	20001	0.285
8	209749	0.280

Price($)	Vol.	No.
0.305	100000	1
0.320	9114	2
0.325	62697	3
0.330	21846	1
0.335	12700	2

Last trade - 16.18pm 19/09/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED - Charts / Financials

Corporate SpotlightNot Yet Available

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available